Format

Send to

Choose Destination
Int J Hematol. 2009 Oct;90(3):328-335. doi: 10.1007/s12185-009-0421-3. Epub 2009 Sep 18.

National questionnaire survey of TMA.

Author information

1
Department of Hematology and Oncology, Mie University Graduate School of Medicine, Mie, Japan.
2
Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Mie, Japan. wadahide@clin.medic.mie-u.ac.jp.
3
Department of Blood Transfusion Medicine, Nara Medical University, Nara, Japan.
4
Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
5
Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government, Tokyo, Japan.
6
Department of Environmental and Occupational Health, Toho University School of Medicine, Tokyo, Japan.
7
Faculty of Science and Engineering, Life Science and Medical Bioscience, Waseda University, Tokyo, Japan.

Abstract

A questionnaire survey of Japanese patients with thrombotic microangiopathy (TMA) was carried out to investigate the frequency, laboratory abnormalities, and outcome in 2004. Out of 185 patients, there were 13 with familial TMA and 172 with acquired TMA. In acquired TMA, there were 66 with Escherichia coli O-157 infection (O-157)-related TMA, 35 with ADAMTS13-related TMA, and 22 with other types of TMA. The frequency of TMA in O-157-related TMA was high in patients from 0- to 15-year-old, and acquired TMA without O-157 was frequently observed in patients ranging from 31 to 65 years of age. In the treatment of acquired TMA, including plasma exchange (PE), steroid, antiplatelet agent, and anticoagulant, PE was carried out in 94.3% of ADAMTS13-related TMA, 77.3% of other TMA, and 7.6% of O-157-related TMA. The efficacy of PE and steroid therapy tended to be higher in ADAMTS13 TMA than in other types of TMA. The complete remission rate is the highest in O-157 TMA. The mortality rate was the lowest for O-157 TMA, and this rate also tended to be lower in ADAMTS13-related TMA than in other types of TMA. However, the determination of ADAMTS13 was not universal in Japan at the time of this questionnaire.

PMID:
19760483
DOI:
10.1007/s12185-009-0421-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center